Search Results 2231-2240 of 21325 for anti-TNF drugs

  1. Trihexyphenidyl (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  2. Tirzepatide (Subcutaneous Route) Proper Use - Mayo Clinic

    Also, exercise regularly and test for sugar in your blood or urine as directed. This medicine comes with a Medication Guide and patient instructions. Read and ...

  3. Afatinib (Oral Route) Description and Brand Names - Mayo Clinic

    This medicine is also used to treat patients with metastatic squamous NSCLC who have received medicines containing platinum but did not work well.

  4. Leukemia Clinical Trials - Mayo Clinic Research

    Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment ... drug Blinatumomab to different doses of standard combination of chemotherapy drugs.

  5. Talc (Intrapleural Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Sclerosol Intrapleural; Steritalc. Descriptions.

  6. Treprostinil (Inhalation Route) Proper Use - Mayo Clinic

    However, the dose is usually not more than 12 breaths per treatment session, 4 times a day. Children—Use and dose must be determined by your doctor. Missed Dose.

  7. Alemtuzumab (Intravenous Route) Proper Use - Mayo Clinic

    You will receive steroid medicines right before starting treatment to prevent allergic reactions and for the first 3 days of each treatment course. You will ...

  8. Coordinated care for innovative treatment of pediatric leukemia - Mayo Clinic

    Mayo Clinic Children's Center offers thorough, accurate diagnoses coupled with individualized therapies provided by highly trained and experienced care ...

  9. Ponatinib (Oral Route) Description and Brand Names - Mayo Clinic

    Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of using it. This medicine is available only ...

  10. A Study Evaluating MM-310 in Patients With Solid Tumors - Mayo Clinic

    ... therapy) prior to the first scheduled dose of MM-310; Received any anti-cancer drug known to have anti-VEGF/VEGFR activity within a period of 5 half-lives of ...